Nanomedicine and Nanoscale Delivery (Focus Group – NND)
virgilio Piccolo, n/a
PhD student
University Federico II, Campania, Italy
PEGylated NPs offer significant advantages for siRNA delivery, including prolonged circulation and reduced immune clearance. However, PEG coating creates a critical barrier that hinders cellular uptake. Stimuli-responsive NPs represent a strategy to overcome the "PEG dilemma”1. We designed the NPs to retain the PEG during circulation but selectively shed it upon specific tumour microenvironment triggers, such as elevated glutathione or external infrared light2. PEG removal exposes the NP core boosting tumour cell uptake, endosomal escape, and siRNA release. This platform enables circulation stealth without compromising intracellular delivery enhancing precision cancer nanomedicine.